These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2563118)

  • 21. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
    Falagas ME; Vardakas KZ
    Clin Microbiol Infect; 2006 Jul; 12(7):603-5. PubMed ID: 16774555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life-threatening cytomegalovirus infection treated with dihydropropoxymethylguanine.
    Creasy TS; Flower AJ; Veitch PS
    Lancet; 1986 Mar; 1(8482):675. PubMed ID: 2869359
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preemptive ganciclovir therapy in renal transplantation.
    Tamm M; Cathomas G; Thiel G
    Ann Intern Med; 1996 Apr; 124(7):693-4. PubMed ID: 8607603
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
    Himmelmann-Jud B; Wüthrich RP; Weinreich T; Binswanger U
    Nephrol Dial Transplant; 1998 May; 13(5):1326-7. PubMed ID: 9623588
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
    Reddy SP; Handa A; Tan L; Devaney A; Hughes D; Mason P; Friend PJ; Darby CR
    Transpl Int; 2003 Oct; 16(10):726-9. PubMed ID: 12827230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients.
    Vila A; Guirado LL; Balius A; Díaz M; Baró E; Olaya M; Andrade M; Agraz I; Solá R
    Transplant Proc; 1999 Sep; 31(6):2335-6. PubMed ID: 10500605
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylaxis of cytomegalovirus infection in renal transplantation.
    Ostermann M; MacPhee I; Chang R
    Nephrol Dial Transplant; 2001 Nov; 16(11):2276-9. PubMed ID: 11682689
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
    Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
    N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preemptive ganciclovir therapy in renal transplantation.
    Brennan DC; Storch GA; Lippman BJ
    Ann Intern Med; 1996 Apr; 124(7):693. PubMed ID: 8607602
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits.
    Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Piperno R; Orsi A; Parri F; Dedola G; Salvadori M
    Transplant Proc; 1998 Aug; 30(5):2094. PubMed ID: 9723402
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG; Winston DJ; Champlin RE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 39. Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.
    Anglicheau D; Lautrette A; Scieux C; Thervet E; Martinez F; Flamant M; Morinet F; Legendre C
    Transplant Proc; 2002 Nov; 34(7):2826-7. PubMed ID: 12431624
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience.
    Jongsma H; Bouts AH; Cornelissen EA; Beersma MF; Cransberg K
    Pediatr Transplant; 2013 Sep; 17(6):510-7. PubMed ID: 23890076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.